Comments on 'Current issues in non-inferiority trials'

[1] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3339 - 3345

[2] *CPMP, 2000, POINTS CONS VAL INT

[3] FLEMING TR, 2007, IN PRESS STATISTICS

[4] GOUGH KR, 1984, LANCET, V2, P659

[5] Koch Armin, 2004, J Biopharm Stat, V14, P315

[6] Statistical consideration of the strategy for demonstrating clinical evidence of effectiveness-one larger vs two smaller pivotal studies [J]. STATISTICS IN MEDICINE, 2005, 24 (11) : 1639 - 1646

[7] Koch GG, 1998, STAT MED, V17, P1863, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1863::AID-SIM989>3.3.CO

[8] 2-D

[9] Kock GG, 1999, DRUG INF J, V33, P1145

[10] Randomization-based nonparametric methods for the analysis of multicentre trials [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2005, 14 (03) : 281 - 301

[1] Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3339 - 3345

[2] *CPMP, 2000, POINTS CONS VAL INT

[3] FLEMING TR, 2007, IN PRESS STATISTICS

[4] GOUGH KR, 1984, LANCET, V2, P659

[5] Koch Armin, 2004, J Biopharm Stat, V14, P315

[6] Statistical consideration of the strategy for demonstrating clinical evidence of effectiveness-one larger vs two smaller pivotal studies [J]. STATISTICS IN MEDICINE, 2005, 24 (11) : 1639 - 1646

[7] Koch GG, 1998, STAT MED, V17, P1863, DOI 10.1002/(SICI)1097-0258(19980815/30)17:15/16<1863::AID-SIM989>3.3.CO

[8] 2-D

[9] Kock GG, 1999, DRUG INF J, V33, P1145

[10] Randomization-based nonparametric methods for the analysis of multicentre trials [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2005, 14 (03) : 281 - 301